You are currently viewing a new version of our website. To view the old version click .

Development of Orally Dispersible Dosage Forms

This special issue belongs to the section “Physical Pharmacy and Formulation“.

Special Issue Information

Dear Colleagues,

In recent years, orally dispersible dosage forms were regarded as high interest research topics and quickly reached the pharmaceutical market as novel patient-centered products. The wide variety of preparation technologies and types of products (i.e., orodispersible tablets/ granules, oral lyophilisates, orodispersible minitablets) led to a dynamic research field that aims to fulfill the administration needs of special groups of patients, such as paediatrics or geriatrics. As the pharmaceutical industry adopts these new products, there is a constant need for innovation in terms of appropriate excipients, product and process development, taste-masking methods, quality assessment methods, and data on end-user perception and acceptability.

This Special Issue wants to map the current research landscape of orally dispersible dosage forms and welcomes original and review papers on all aspects of their design, development, manufacturing, characterization, administration or use.

Dr. Sonia M. Iurian
Prof. Dr. Ioan Tomuta
Dr. Catalina Bogdan
Dr. Tibor Casian
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • orally dispersible dosage forms
  • oral lyophilisates
  • thin films
  • orodispersible films
  • orodispersible minitablets

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923